NEW YORK (GenomeWeb News) – The Department of Defense has awarded more than $23 million to three firms for the development of a platform and assays to detect biological warfare agents, the agency announced last week.

BioFire Diagnostics, Focus Diagnostics, and IQuum will share the $23.1 million cost-plus-fixed-fee multiple award task order contract being awarded through the US Army to develop a US Food and Drug Administration-cleared diagnostic platform and related FDA-cleared biological warfare agent in vitro diagnostic assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.